Skip to content
FDA drug shortage status

Is Pramlintide Acetate Injection (Symlinpen) in shortage?

Pramlintide Acetate Injection is listed by FDA as being discontinued by at least one maker (updated Oct 27, 2025).

Being discontinuedFDA status
2packages listed
0unavailable

Every listed package

FDA tracks shortages per package. What each maker reports, most recently updated first:

  • SymlinPen® 60 , Injection, 1000 ug/1 mL (NDC 0310-6615-02)
    AstraZeneca ABBeing discontinuedUpdated Oct 27, 2025Discontinued Oct 27, 2025

    Discontinuation of the manufacture of the drug.

    Maker contact: 800-236-9933

  • SymlinPen® 120 , Injection, 1000 ug/1 mL (NDC 0310-6627-02)
    AstraZeneca ABBeing discontinuedUpdated Oct 27, 2025Discontinued Oct 27, 2025

    Discontinuation of the manufacture of the drug.

    Maker contact: 800-236-9933

Pramlintide Acetate Injection shortage questions

Is Pramlintide Acetate Injection (Symlinpen) in shortage?

Pramlintide Acetate Injection is listed by FDA as being discontinued by at least one maker (updated Oct 27, 2025).

What should I do if I can’t get Pramlintide Acetate Injection?

Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.

Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.